Delivery Order SPE2DB25D9322-SPE2DB25FWAEL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device, with a period of performance through January 10, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,811.55 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued on July 21, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The company leverages...
- The Defense Logistics Agency (DLA) awarded a $15,623.10 delivery order to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 17, 2025, with an ultimate completion date of October 8, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- SPE2DB25D9322Indefinite Delivery Contract
- SPE2DB25D9322-SPE2DB25FWAELDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. The company will supply the contraceptive device directly to support Department of Defense healthcare requirements. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This parent contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to military health facilities worldwide. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently providing branded and generic prescription drugs, biologics, and medical consumables to defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/14/25 |